All Stories

  1. Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17α-Ethynylestradiol

    Article • Drug Metabolism and Disposition, March 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Paul Hollenberg

  2. Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds

    Article • Drug Metabolism and Disposition, July 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Paul Hollenberg

  3. Roles of Residues F206 and V367 in Human CYP2B6: Effects of Mutations on Androgen Hydroxylation, Mechanism-Based Inactivation, and Reversible Inhibition

    Article • Drug Metabolism and Disposition, August 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Paul Hollenberg

  4. Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Paul Hollenberg

  5. Hydroxylation andN-Dechloroethylation of Ifosfamide and Deuterated Ifosfamide by the Human Cytochrome P450s and Their Commonly Occurring Polymorphisms

    Article • Drug Metabolism and Disposition, May 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Paul Hollenberg